physioneal 40 glucose 38,6 mg/ml
baxter medical ab - glukosemonohydrat / natriumklorid / kalsiumkloriddihydrat / magnesiumkloridheksahydrat / natriumhydrogenkarbonat / natriumlaktat - peritonealdialysevæske - 42.5 mg/ ml / 5.38 mg/ ml / 0.184 mg/ ml / 0.051 mg/ ml / 2.1 mg/ ml / 1.68 mg/ ml
glucos fresenius kabi 50 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 50 mg/ ml
glucos fresenius kabi 100 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 100 mg/ ml
glucos fresenius kabi 200 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 200 mg/ ml
glucos fresenius kabi 500 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 500 mg/ ml
benelyte
fresenius kabi norge as - natriumklorid / kaliumklorid / kalsiumkloriddihydrat / magnesiumkloridheksahydrat / natriumacetattrihydrat / glukosemonohydrat - infusjonsvæske, oppløsning - 6.429 mg/ ml / 0.298 mg/ ml / 0.147 mg/ ml / 0.203 mg/ ml / 4.082 mg/ ml / 10 mg/ ml
natriumklorid-glucos baxter viaflo 9 mg/ ml / 50 mg/ ml
baxter as - natriumklorid / glukose - infusjonsvæske, oppløsning - 9 mg/ ml / 50 mg/ ml
paracetduo 500 mg / 65 mg
karo pharma oslo as - paracetamol / koffein - tablett - 500 mg / 65 mg
glucos baxter viaflo 50 mg/ ml
baxter medical ab - glukosemonohydrat - infusjonsvæske, oppløsning - 50 mg/ ml
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.